Products for Research Use Only
RegisterLogin

Mibavademab

CAT: 0804-HY-P990631-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P990631-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Mibavademab is a CHO-expressed humanized antibody that targets LEPR/CD295. Mibavademab is equipped with a huIgG4SP heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145.58 kDa. The isotype control for Mibavademab can be referenced as Human IgG4 kappa, Isotype Control.
CAS Number
2305770-44-7
UNSPSC
12352203
Target
Neuropeptide Y Receptor
Type
Inhibitory Antibodies
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/mibavademab.html
Purity
99.90
Molecular Weight
(145.58 kDa)
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
T9901A-518-01Mibavademab
GTR18612665-01Mibavademab Antibody
MBS1563743-01Research Grade Mibavademab
E55B0802Mibavademab (Reference antibody)
21-931Mibavademab - Research Grade Biosimilar
ICH5258-20mgMibavademab Biosimilar - Research Grade
GTR18780707-01(Mibavademab) Biosimilar Reference Antibody
A2413-1mg*5Mibavademab (Anti-LEPR / CD295)
A138869Mibavademab Biosimilar (Monoclonal, IgG4)
GTR18697353-01Mibavademab Human Monoclonal Antibody

Popular Products